Although IL-1 stimulates cellular responses in both lymphoid and nonlymphoid cells, the second messengers by which IL-1 activates cells are unknown. Recombinant IL-la (rIL-l) is a comitogen for glomerular mesangial cells. Using this model we explored potential transmembrane signals by which IL-1 stimulates cellular responses. Certain mitogens hydrolyze inositol phospholipids by phospholipase C to generate 1,2-diacylglycerol, a cofactor for protein kinase C, and inositol (1,4,5)-trisphosphate, which mobilizes intracellular calcium. rIL-1 induced a peak increase in pHJ1,2-diacylglycerol formation at 1 min. Production of 1,2-diacylglycerol often parallels the generation of phosphatidic acid; however, rIL-l stimulated I32Plphosphatidate formation only after 60 min. rIL-1 did not change the inositol phosphate or cytosolic free calcium concentrations, demonstrating that rIL-l does not activate an inositol phospholipid-specific phospholipase C. [3HjPhosphoryl-ethanolamine, but not VHlphosphorylserine or V3Hlphospho-rylcholine, was maximally elevated at 1 min in mesangial cells incubated with rIL-1. Radioactivity incorporated into phosphatidylethanolamine but not phosphatidylcholine was also decreased in IL-1-stimulated mesangial cells compared with control at 1 min. These data suggest that rIL-1 activates a phospholipase C predominantly linked to phosphatidylethanolamine. In contrast to other mitogens, rIL-1 did not alter intracellular pH. Both 12-0-tetradecanoyl-phorbol-13-acetate, a homologue of 1,2-diacylglycerol, and phosphatidate but not phosphatidylcholine in the presence of 0.5% fetal bovine serum stimulated mesangial cell proliferation. rIL-1-induced cellular activation may be mediated, at least in part, by phospholipidderived second messengers generated through novel pathways.
Introduction
IL-1 represents a family of proteins, encoded by at least two distinct genes, that play a seminal role in systemic and local inflammatory responses (1) . When incubated with IL-1, primary cells as well as cultured cell lines undergo a coordinated response that culminates in the expression of new structural determinants and functional characteristics (1) . Little information is available, however, on the transmembrane messengers mediating IL-1-induced cellular activation. Our objective in this study was to explore the phospholipid-derived and ionic signals that may mediate the effects of IL-I on cultured rat glomerular mesangial cells.
The mesangial cell occupies a central anatomical position within the glomerulus. It is a specialized pericyte that not only regulates glomerular filtration but also synthesizes, and responds to, a number ofcytokines (2) . Mesangial cells in culture contain IL-I mRNA transcripts and release a protein that closely resembles IL-1 (3, 4) . Both macrophage-and mesangial cell-derived IL-I stimulate mesangial cells to proliferate and generate PGE2 and collagen (4) . IL-I also enhances mesangial cell secretion of a glomerular basement membrane-degrading neutral protease (4) . IL-1 gene expression is increased in kidneys of animals with experimental nephritis (3), and considerable evidence has demonstrated that IL-1 acts locally to enhance tissue injury (1) . Intraglomerular release of IL-1, therefore, may contribute to the structural and functional changes characteristic of glomerular immune injury.
Methods
Cell culture and DNA synthesis. Mesangial cells were grown from collagenase-digested glomeruli as previously described (3) and represent a uniform population of cells that is not contaminated by macrophages, endothelial cells, fibroblasts, or epithelial cells using morphological, immunohistochemical, and biochemical criteria (3) . Cells were used in the third to sixth passage. To assess DNA synthesis, near confluent mesangial cells were held for 96 h in DME and Hamm's nutrient F12 medium (DME/Fl2, 1:1) containing 0.5% fetal bovine serum (FBS) .' Cells remain viable but do not proliferate under these conditions. Cells were then incubated for 48 h with the indicated agents and [3H]thymidine (1 jsCi/ml) before the determination of acid-insoluble counts. In selected experiments after the holding period, the growth medium was changed to a defined medium constituted by supplementing DME/F12 with BSA (1 mg/ml), liposomes (50 ,g/ml; 1 ) for 24 h to measure both water-soluble phosphorylbases and the polar phosphoglycerides. Preliminary experiments demonstrated that steady-state incorporation of tracer into both rapidly and more slowly labeled phospholipids had occurred by the end of the labeling period. At the time of the experiment, unless otherwise indicated, radioisotope was removed, the monolayers were gently washed, radiolabel-free, ice-cold Krebs-Henseleit-Hepes (20 mM) buffer was added, and the cells were rewarmed to 37°C. rIL-1 at the indicated dose in 0.2% BSA or vehicle was added for~the designated times. The incubations were terminated after various intervals with 1 ml ice-cold methanol, and the cells scraped and transferred into 1 ml chloroform. A second methanol wash was added and after 30 min at 4°C the methanol and chloroform volumes were adjusted to yield two phases (chloroform/methanol/water, 1: 1:0.9, vol/vol/vol). The chloroform lipid extracts were washed twice, dried under N2, and resuspended in 75% chloroform/25% methanol. The samples and appropriate standards were spotted on silica gel 60-plates (250-Mm thickness; EM Science, Gibbstown, NJ). Neutral lipids were eluted from the origin with a mobile phase consisting of benzene/diethylether/ammonia (100/80/0.2, vol/vol/vol) (5). DAG was well separated from 1,3-DAG, monoacylglycerol, triacylglycerol, phospholipids, and free arachidonate. The neutral lipids were visualized by toluidino-2-naphthalene-sulfonic acid spray and ultraviolet light. The lipids that comigrated with authentic DAG were scraped and radioactivity was determined in a liquid scintillation counter. Phosphatidic acid (PA) was resolved from the other major polar phosphoglycerides by using a one-dimensional, dual phase solvent system. After eluting with chloroform/methanol/4.3 M NH40H (34:26:8, vol/vol/vol) until the solvent front was 8 cm from the origin, the plates were dried. Subsequently, the plates were run in the same direction with hexane/diethylether/acetic acid (70:30:2, vol/vol/vol) to the top of the plate (15 cm). PA that comigrated with the authentic standards was scraped and incorporated radioactivity counted. Water-soluble extraction products containing radiolabeled phosphorylbases were spiked with the appropriate unlabeled phosphorylbases, redissolved in 50% ethanol, and separated by TLC with methanol/0.5% NaCl/ammonia (100:100:2, vol/vol/vol) (6).
Phosphorylcholine (PC) was visualized by iodine, and the phosphorylethanolamine (PE) and phosphorylserine derivatives were identified by spraying with ninhydrin spray. The phosphorylated and unphosphorylated forms of the bases were well separated from each other and comigrated with authentic standards. In these experiments the lipid fraction containing the corresponding radiolabeled polar phosphoglycerides and authentic standards were separated using a mobile phase of chloroform/methanol/acetic acid/H20 (65:35:1:8, vol/vol/ vol/vol). Where indicated, extracted lipids were assayed for elemental phosphate (7), and cell protein content was determined by the method of Lowry (8) .
Polyphosphoinositide formation and measurement of cytosolic free calcium ([Ca2+]) and pH (pH,). The measurement of water-soluble inositol phosphates (IPn) was performed as previously described using anion-exchange chromatography (9 at 339/500 nm excitation/emission wavelengths. The Ca2+-dependent emission was calibrated at the end of each individual experiment as described, using ionomycin and EGTA/Tris HCI, pH 10.5 (9). To determine pHi, monolayers were loaded with 3 MM 2',7'-bis(carboxylethyl)-5(6)-carboxy-fluorescein-penta-acetoxy methylester (Molecular Probes Inc., Junction City, OR) for 30 min at 370C followed by a 20-min incubation in 2',7'-bis(carboxylethyl)-5(6)-carboxy-fluorescein-penta-acetoxy methylester-free medium (10) . Fluorescence ratios at 440/500 nm excitation and 540 nm emission wavelengths were recorded with a dual wavelength Bioinstrumentation Group fluorometer (University of Pennsylvania, Philadelphia, PA) for up to 15 min after addition of rIL-l (10 ng/ml). To calculate pHi, fluorescence readings were obtained at the end of each experiment after replacement of the medium with modified Krebs-Henseleit-Hepes buffer (Na' isosmotically substituted by K+) at pH of 6.5, 7.0, and 7.5 in the presence ofthe K+/H' ionophore, nigericin (3 Ag/ml) (10) . Linearity of the fluorescent emission in the 6.5-7.5 pH range was preliminarily established.
Results Table I demonstrates that rIL-1 is a comitogen for the mesangial cell. rIL-1 in the presence of 0.5% FBS induced a significant dose-dependent increase in DNA synthesis, measured as
[3H]thymidine incorporation in quiescent mesangial cells (Table I) . DNA synthesis was not initiated in quiescent cells either by rIL-l in the absence of serum (98.6±9 and 90.8±5.9% of control for rIL-1, 1.0 and 10 ng/ml, respectively, n = 4) or by denatured (100°C for 60 min) rIL-l in the presence of serum (95±3.4, 101.7±4.7, and 102±3.0% of control for rIL-1, 0.1, 1, and 10 ng/ml, respectively, n = 2). This data suggests that a comitogen supplied by serum is necessary for IL-1-induced mesangial cell mitogenesis, and confirms studies using partially purified macrophage supernatants as sources of IL-1 (4). To address this issue further, we used a fully defined medium that supports mesangial cell growth. DNA synthesis was stimulated in G0-arrested cells by changing from holding to defined medium. Addition of fibroblast growth factor (FGF) at submitogenic concentrations or rIL-1 did not further enhance DNA synthesis. However, rIL-1 and FGF synergistically increased [3H]thymidine incorporation (184±6% of control, n = 3). These studies demonstrate that rIL-1 is a comitogen for the mesangial cell, but the transmembrane signals induced by rIL-1 alone are not sufficient to cause mesangial cell proliferation. We next studied early biochemical events, postulated to initiate proliferation and cellular responses mediated by other cytokines, that could also be generated by IL-1 and that could, in part, contribute to mesangial cell mitogenesis. Studies describing the initial second messengers generated by mitogens have concentrated on the hydrolysis of inositol phospholipids (PtdIns) by a phosphodiesterase, phospholipase C (1 1). This pathway produces DAG, a cofactor for protein kinase C, and IPn including IP3, which mobilizes calcium from nonmitochondrial, intracellular stores. We measured the generation of DAG in control and rIL-1-stimulated mesangial cells to identify an IL-1-activated phospholipase C. Compared with control, rIL-1 induced a time-dependent, statistically significant increase of [3H]arachidonate-labeled DAG (Fig. 1 A) . Maximal stimulation (192±33%, n = 5) occurred at 1 min and subsequently decreased after 5 min to 119±12% and remained elevated at that level for 60 min. The maximal stimulation of DAG at 1 min occurred with concentrations of rIL-1 between 1 and 10 ng/ml, although concentrations as low as 0.1 ng/ml had an effect (data not shown). In intact cells, DAG may be rapidly phosphorylated to PA by DAG kinase (12) . Therefore, to amplify DAG formation, we next preincubated mesangial cells for 15 min with the DAG kinase inhibitor R59 022 (13) . rIL-1 induced a marked and prolonged increase in DAG formation ( Fig. 1 B) 022). The data represent the mean±SEM of replicate determination of two experiments. Two-way ANOVA established a significant (P < 0.05) difference between rIL-l-treated and control groups. levels comparable to those measured in the absence of R59 022 by 60 min.
The formation of DAG and PA are often temporally coincident (12, 14) . As a consequence, we expected an increase in PA to parallel the formation of DAG in rIL-1-stimulated mesangial cells. Rather than a rapid peak, rIL-1 significantly stimulated [32P]PA formation only after rather prolonged incubations of60 min (Fig. 2 A) . As spectively) and returned to baseline before the rIL-1-induced increase. Phosphorylation of DAG by DAG kinase may result in the formation of PA (12) . The DAG kinase inhibitor R59 022 had no effect on rIL-1-induced increases in [32P]PA levels (Fig. 2 B) Fig. 3 A, Na+/H+ exchange can also be initiated by kinase C-independent mechanisms (17) . Since rIL-1-stimulated DAG formation could activate protein kinase C, we measured pH, in control and rIL-l-stimulated mesangial cells. In contrast to other mitogens, rIL-1 did not induce an acute change in [pH] , in mesangial cells (Fig. 3 B) . AVP, however, induced a rapid, transient acidification followed by sustained cytoplasmic alkalinization (Fig. 3 B) . Second messengers should mimic the cytokine-stimulated cellular response. Both 12-0-tetradecanoyl-phorbol-13-acetate, a homologue for endogenous DAG, and egg yolk lecithin PA, in the presence of 0.5% serum, stimulated mesangial cell DNA synthesis as measured by [3H]thymidine incorporation (Table  I) . In contrast, PtdCho had no effect on mesangial cell DNA synthesis. Similar to the conditions necessary for rIL-l-stimu- 
Discussion
Little information describing the transmembrane signals generated by IL-1 has previously been published. Although both IL-1a and IL-13 stimulated amiloride-sensitive Na+/H' exchange after 1 h in the transformed pre-B lymphocyte cell line 70Z/3, intracellular alkalinization or increased cytosolic Na' was not necessary for Il-1-mediated 70Z/3 differentiation (18). We did not monitor pHi in prolonged incubations but were clearly unable to demonstrate the acute changes in pHi that have been observed in response to other cytokines and hormones (17) . Other workers have also failed to show any effects of IL-1 on [Ca2+]i concentration or Ptdlns turnover (19, 20) .
These data suggest that other transmembrane signals mediate at least some of IL-l's biological effects.
We have demonstrated a rapid rIL-1-stimulated increase in DAG. Although we used only IL-1 a in these studies, both IL-1 a and IL-1,8 share a common receptor despite being only distantly homologous, and thus far have been shown to have only quantitatively but not qualitatively different biologic actions. DAG is a phospholipid-derived signal that can activate protein kinase C, and Levine and Xiao have suggested that IL-I directly or indirectly stimulates kinase C activity in both liver and smooth muscle cells (21) . Other studies that use lymphocytes as targets of IL-1 suggest IL-1 elicits cellular responses by a mechanism that involves neither an increase in
[Ca>]i nor stimulation of protein kinase C activity (19, 20) .
These findings suggest that IL-1-stimulated DAG may induce signals independent of protein kinase C activation. Recent evidence is consistent with this hypothesis. FGF, like rIL-1, stimulates DAG formation independent of polyphosphoinositide turnover, but does not activate protein kinase C (22) . Priming and primed stimulation of neutrophils by 1-oleoyl-2-acetylglycerol occurs by mechanisms distinct from kinase C translocation (23) . Desensitization or inhibition of protein kinase C only partially reduced the amplification of bradykininstimulated PGE2 synthesis by DAG analogues (24) . The fatty acid composition of agonist-stimulated DAG formation may be a critical determinant of its ability to activate protein kinase C (25) . Targets of DAG other than kinase C have not been identified but Nishizuka has suggested that DAG may be a source of arachidonate. Eicosanoids have been implicated previously as components of IL-I-stimulated transmembrane signal pathways (26) .
DAG formation may be the result of two separate pathways. Phosphohydrolase activity generates DAG from PA produced by de novo synthesis from glycerol, a pathway of importance in insulin transmembrane signaling (14) . Both the lack of a coincident rise in rIL-1-stimulated DAG and PA formation in our studies and the evidence suggesting that lipid mass is constant argue against, but do not disprove, this mechanism. DAG is also produced by receptor-mediated phospholipase C activity (11) . Our findings suggest rIL-I-generated DAG is the result of a phospholipase C that is distinct from a PtdIns-specific phosphodiesterase and that predominantly hydrolyzes PtdEth. rIL-1-stimulated DAG peaked at 1 min, coincident with an increase in the phospholipase C hydrolysis product [3H]PE and a decrease in [3H]PtdEth. However, these results need to be confirmed by mass measurements since a recent study has demonstrated discrepancies in lipid measurements obtained using label and those obtained using mass (27) .
Others have suggested that phospholipids other than PtdIns are substrates for phospholipase C. FGF increased DAG independent to PtdIns hydrolysis, but the phospholipid source of the DAG was not determined (22) . A neutral active phospholipase C specific for PtdCho and PtdEth has been isolated from myocardium (28) . Bestermen et al. reported that phorbol dibutyrate stimulated DAG and PC accumulation in Swiss 3T3 cells (16) and hypothesized that protein kinase C, activated directly by phorbol esters or indirectly by DAG produced by agonist-induced PtdIns turnover, stimulates a PtdCho-specific phospholipase C. Subsequent work has suggested that GTP-binding proteins rather than kinase C directly mediate activation of a PtdCho-linked phospholipase C (29) . Consistent with this observation, the Ha-ras protein, which has GTP-binding, protein-like activities, stimulates phospholipase C-mediated hydrolysis of PtdEth as well as PtdCho but not PtdIns (6) . However, IL-1 is the only example of peptide hormone-or cytokine-mediated activation of phospholipase C in the absence of concomitant PtdIns hydrolysis.
Since others have suggested that phosphorylation of DAG by DAG kinase is a major pathway of DAG metabolism, we were surprised to find that peak rIL-1-stimulated DAG production occurred at 1 min in the absence of measurable PA formation. However, PA formation did occur after 60 min in the absence of significant DAG formation. Although the DAG kinase inhibitor R59 022 potentiated the effect of rIL-1 on DAG generation, our results suggest that this pathway is quantitatively unimportant in PA formation in rIL-1-treated mesangial cells. It might be argued that at least some PA should be produced concurrent with peak IL-l -stimulated DAG formation since the DAG kinase inhibitor potentiates the response. We may be unable to detect by radiolabeling small changes in PA production at 1 min since changes in lipid mass are underestimated when assessed by radiolabel incorporation (27) . In addition, formation of PA by phosphorylation of DAG may depend on the fatty acids in the 1,2-sn configuration of the DAG. Platelet-derived growth factor-stimulated DAG kinase exhibits substrate specificity that preferentially phosphorylates 18:0/20:4 DAG over didecanoylglycerol (30) 
